A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

about

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

Item

http://www.wikidata.org/entity/Q42279324

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@en

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@nl

type

Item

label

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@en

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@nl

prefLabel

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@en

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@nl

P1476

A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.

@en

P2093

Hideto Yamada

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Nishijima

http://www.w3.org/2001/XMLSchema#string

Satoshi Nagamata

http://www.w3.org/2001/XMLSchema#string

Takeo Miyamoto

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Ebina

http://www.w3.org/2001/XMLSchema#string

Yumika Yamano

http://www.w3.org/2001/XMLSchema#string

P2860

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

Uterine sarcomas: a review.

Pazopanib: Clinical development of a potent anti-angiogenic drug.

P304

E45-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27578036

http://www.w3.org/2001/XMLSchema#string

P932

5425135

http://www.w3.org/2001/XMLSchema#string